OpenVSafe by OpenVAERS
Search V-safe

98V-33312-83615

2 vaccinations 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
973 / OR
Registered
2022-01-06
Relationship
Child or adolescent in my care
Guardian
4BB-33350-52803
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-10
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-01
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-06
    Registered in v-safe
  4. 2022-01-06
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  5. 2022-01-12
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  6. 2022-03-02
  7. 2022-06-02
  8. 2022-12-03
    Survey response — 12 months, dose 2, dependent
    MedDRA: Nasopharyngitis — Feeling: Good
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-10Pfizer-BioNTech No
22021-12-01Pfizer-BioNTech No

Free text

Release 12 — 12 months, dose 2, dependent

2022-12-03

Symptoms: Cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release